Cha YJ - Search Results

1

Dynamic changes in PD-L1 expression and CD8⁺ T cell infiltration in non-small cell lung cancer following chemoradiation therapy.

Choe EA, Cha YJ, Kim JH, Pyo KH, Hong MH, Park SY, Shim HS, Jung I, Lee CY, Cho BC, Kim HR. Choe EA, et al. Among authors: cha yj. Lung Cancer. 2019 Oct;136:30-36. doi: 10.1016/j.lungcan.2019.07.027. Epub 2019 Aug 1. Lung Cancer. 2019. PMID: 31421259

2

Screening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangements.

Cha YJ, Lee JS, Kim HR, Lim SM, Cho BC, Lee CY, Shim HS. Cha YJ, et al. PLoS One. 2014 Jul 24;9(7):e103333. doi: 10.1371/journal.pone.0103333. eCollection 2014. PLoS One. 2014. PMID: 25058391 Free PMC article.

3

Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.

Shim HS, Kenudson M, Zheng Z, Liebers M, Cha YJ, Hoang Ho Q, Onozato M, Phi Le L, Heist RS, Iafrate AJ. Shim HS, et al. Among authors: cha yj. J Thorac Oncol. 2015 Aug;10(8):1156-62. doi: 10.1097/JTO.0000000000000579. J Thorac Oncol. 2015. PMID: 26200269 Free article.

4

A Case of ALK-Rearranged Adenocarcinoma with Small Cell Carcinoma-Like Transformation and Resistance to Crizotinib.

Cha YJ, Cho BC, Kim HR, Lee HJ, Shim HS. Cha YJ, et al. J Thorac Oncol. 2016 May;11(5):e55-e58. doi: 10.1016/j.jtho.2015.12.097. Epub 2015 Dec 29. J Thorac Oncol. 2016. PMID: 26752677 Free article.

5

Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status.

Cha YJ, Kim HR, Lee CY, Cho BC, Shim HS. Cha YJ, et al. Lung Cancer. 2016 Jul;97:73-80. doi: 10.1016/j.lungcan.2016.05.001. Epub 2016 May 3. Lung Cancer. 2016. PMID: 27237031

6

Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants.

Cha YJ, Kim HR, Shim HS. Cha YJ, et al. J Transl Med. 2016 Oct 19;14(1):296. doi: 10.1186/s12967-016-1061-z. J Transl Med. 2016. PMID: 27756333 Free PMC article.

7

Clinical course of stage IV invasive mucinous adenocarcinoma of the lung.

Cha YJ, Kim HR, Lee HJ, Cho BC, Shim HS. Cha YJ, et al. Lung Cancer. 2016 Dec;102:82-88. doi: 10.1016/j.lungcan.2016.11.004. Epub 2016 Nov 6. Lung Cancer. 2016. PMID: 27987593

8

Validation of ALK/ROS1 Dual Break Apart FISH Probe probe in non-small-cell lung cancer.

Lim SM, Chang H, Cha YJ, Liang S, Tai YC, Li G, Pestova E, Policht F, Perez T, Soo RA, Park WY, Kim HR, Shim HS, Cho BC. Lim SM, et al. Among authors: cha yj. Lung Cancer. 2017 Sep;111:79-83. doi: 10.1016/j.lungcan.2017.07.016. Epub 2017 Jul 12. Lung Cancer. 2017. PMID: 28838404

9

Detection of activating and acquired resistant mutation in plasma from EGFR-mutated NSCLC patients by peptide nucleic acid (PNA) clamping-assisted fluorescence melting curve analysis.

Kim CG, Shim HS, Hong MH, Cha YJ, Heo SJ, Park HS, Kim JH, Lee JG, Lee CY, Cho BC, Kim HR. Kim CG, et al. Among authors: cha yj. Oncotarget. 2017 May 10;8(39):65111-65122. doi: 10.18632/oncotarget.17786. eCollection 2017 Sep 12. Oncotarget. 2017. PMID: 29029416 Free PMC article.

10

Biology of invasive mucinous adenocarcinoma of the lung.

Cha YJ, Shim HS. Cha YJ, et al. Transl Lung Cancer Res. 2017 Oct;6(5):508-512. doi: 10.21037/tlcr.2017.06.10. Transl Lung Cancer Res. 2017. PMID: 29114467 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters